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Caspases are evolutionary conserved cysteine 
proteases with a very important role in apopto-
sis (1). Caspase-1, however, is best known for 
its role in infl  ammation and innate immune re-
sponses to microbial pathogens (2). Caspase-1 
activation takes place upon assembly of the 
“infl  ammasome,” a signaling platform scaf-
folded by proteins belonging to the NOD-LRR 
family (2). Activated caspase-1 is responsible 
for the processing and maturation of the pro-
infl  ammatory cytokines IL-1β and IL-18 (3), 
which are important in host defense against a 
variety of pathogens. Consequently, caspase-
1–defi  cient mice are more susceptible to sev-
eral pathogens (4–6) but more resistant to the 
toxic eff  ect of lipopolysaccharide (7).
Surprisingly, caspase-1 defi  ciency was shown 
to confer resistance to oral infection with the 
  enteropathogen  Salmonella enterica serovar 
  Typhimurium (Salmonella typhimurium) (8). This 
bacterium induces caspase-1–dependent death 
of macrophages upon infection (9–11). This type 
of death diff  ers from conventional apoptosis in 
that it occurs very rapidly and does not exhibit 
some of its canonical features. Because in acti-
vated macrophages this rapid death apparently 
occurs with release of proinfl  ammatory  cyto-
kines, it was proposed that caspase-1 was re-
quired for S. typhimurium to colonize the Peyer’s 
patches (PPs) and cross the intestinal barrier (8).
The caspase-1–dependent macrophage 
death induced by Salmonella is dependent on 
the function of a type III secretion system 
(TTSS) encoded within its pathogenicity is-
land-1 (SPI-1) (9, 10). It has been proposed that 
SipB, one of the proteins secreted and translo-
cated into host cells by this TTSS, is responsible 
for this death by directly binding and activating 
caspase-1 (12). However, because ipaf−/− mac-
rophages are also resistant to this death (13), 
caspase-1 activation by S. typhimurium is most 
likely not mediated by direct binding of SipB 
to caspase-1.  Shigella fl   exneri, another enteric 
pathogen, causes a virtually identical caspase-1–
dependent macrophage death (14). Paradoxi-
cally, caspase-1 defi   ciency renders mice 
signifi  cantly more susceptible to infection with 
this pathogen (4). Furthermore, administration 
of IL-18 or IL-1β or neutralizing antibodies to 
these cytokines increases the resistance or sus-
ceptibility of mice to S. typhimurium infection, 
respectively (15–18). These apparent paradoxes 
prompted us to reexamine the role of caspase-1 
in S. typhimurium pathogenesis.
RESULTS AND DISCUSSION
We fi  rst reexamined the role of caspase-1 in 
controlling S. typhimurium infection. We fi  rst 
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confi  rmed the genotype of caspase-1−/− mice by PCR geno-
typing (not depicted) and, functionally, by the resistance of 
their bone marrow–derived macrophages (BMDMs) to the 
rapid death induced by S. typhimurium (Fig. 1 A). The mouse 
nramp1 (Slc11a1) gene controls the resistance or susceptibility 
of mice to several unrelated pathogens, among them S. ty-
phimurium (19). Common laboratory mouse strains such as 
C57BL/6 and BALB/c carry a mutant nramp1, which renders 
them up to 1,000-fold more susceptible to S. typhimurium 
than strains harboring the wild-type allele (19). Knockout 
mouse lines are most frequently constructed using 129-
derived embryonic stem (ES) cells, which have a wild-type 
nramp1 allele. However, defi  cient animals are also frequently 
backcrossed into another genetic background, such as that of 
C57BL/6, with a mutant copy of nramp1. Given these consid-
erations and because nramp1 is the main genetic determinant 
of S. typhimurium susceptibility/resistance in mice, we deter-
mined the nramp1 status of the control and knockout mice 
used in these studies. As seen in Fig. 1 B, mice carried a mu-
tant copy of the nramp1 gene and are therefore “Salmonella 
susceptible.” We used these mice to reevaluate the infl  uence 
of caspase-1 in susceptibility to S. typhimurium oral infection. 
Caspase-1−/− and control mice were infected orally with 105 
S. typhimurium ( 10 LD50 for an nramp1−/− mouse). As ex-
pected for this dose, all control mice died during the experi-
ment. However, unlike previously reported, caspase-1−/− 
mice did not show increased resistance to bacterial infection 
and succumbed to infection more rapidly than the caspase-
1+/+ control animals (Fig. 1 C). These results indicate that in 
the context of Nramp-1 defi  ciency, the absence of caspase-1 
does not confer resistance to S. typhimurium oral infection, but 
rather, increases the susceptibility to this pathogen. We also 
quantifi  ed the bacterial loads in the spleens and mesenteric 
LNs (MLNs) of mice 5 d after oral administration of 106 S. 
  typhimurium. Consistent with the previous result, signifi  cantly 
Figure 1.  Susceptibility of caspase-1−/−nramp-1−/− mice to 
S. typhimurium infection. (A) To confi  rm the caspase-1−/− status, which 
confers resistance to Salmonella-induced macrophage death, BMDMs 
obtained from caspase-1+/+nramp-1−/− and caspase-1−/−nramp-1−/− 
mice were infected with S. typhimurium, and macrophage death was eval-
uated by the release of LDH. (B) Nucleotide sequence profi  le of the nramp-1 
allele. The arrow indicates the presence of the mutation G to A leading 
to the change of a glycine for aspartic acid at position 169, which results 
in a loss of function. (C) Mice were infected orally with 105 S. typhimurium, 
and survival was monitored over time. (D) Mice were infected orally with 
106 S. typhimurium, and bacterial loads in the spleens and MLNs were 
determined 5 d after infection (p-values for the difference in bacterial 
loads in caspase-1−/−nramp-1−/− and caspase-1+/+nramp-1−/− mice 
were P = 0.02 and P < 0.0001 for the spleens and MLNs, respectively).
Figure 2.  Susceptibility of caspase-1−/−nramp-1+/+ mice to 
S. typhimurium infection. (A) To confi  rm the caspase-1−/− status, BMDMs 
obtained from caspase-1+/+nramp-1+/+ and caspase-1−/−nramp-1+/+ 
mice were infected with S. typhimurium, and macrophage death was eval-
uated by the release of LDH. (B) Nucleotide sequence confi  rmed the pres-
ence of the wild-type nramp1 allele. The arrow indicates a wild-type codon 
at position 169 (see Fig.1). (C) Mice were infected orally with 106 S. ty-
phimurium, and survival was monitored over time. (D) Mice were infected 
orally with 107 S. typhimurium, and bacterial loads in the spleens and 
MLNs were determined 5 d after infection (p-values for the difference in 
bacterial loads in caspase-1−/−nramp-1+/+ and caspase-1+/+nramp-1+/+ 
mice were P = 0.0016 and P < 0.0001 for the spleens and MLNs, respec-
tively). (E) Mice were infected orally with 106 (nramp-1−/− background) or 
107 (nramp-1+/+ background) S. typhimurium, and bacterial loads in PPs 
were determined 5 d after infection (p-values for the difference in bacte-
rial loads between caspase-1+/+nramp-1−/− vs. caspase-1−/−nramp-1−/− 
and between caspase-1+/+nramp-1+/+ vs. caspase-1−/−nramp-1+/+ mice 
were P = 0.114 and P = 0.222, respectively).JEM VOL. 203, June 12, 2006  1409
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higher numbers of bacteria were present in the organs of 
  caspase-1−/− mice (P = 0.002 and P < 0.0001 for spleens and 
MLNs, respectively; Fig. 1 D). Collectively, these results in-
dicate that the absence of caspase-1 in the context of a non-
functional nramp1 allele does not result in increased resistance 
to orally administered S. typhimurium. The observation of 
higher bacterial loads in systemic tissues of the caspase-1−/−–
defi  cient animals indicates that caspase-1 is most likely not 
  required for these bacteria to cross the intestinal barrier as 
  reported previously (8). It is not clear why these results diff  er 
from the previous report. It is possible that the diff  erent results 
may be due to the use of a diff  erent caspase-1–defi  cient line 
because the previous studies were conducted with an inde-
pendently generated caspase-1−/− mouse in a B10.RIII back-
ground. Previous studies have reported that this background 
exhibits a more pronounced Th1 polarization of the immune 
response (20). However, more studies will be necessary to de-
termine the bases for the diff  erences in the fi  ndings.
To investigate whether the phenotype associated with 
the absence of caspase-1 could be masked by the absence of 
a functional nramp1 allele, we crossed the wild-type nramp1 
allele into the caspase-1−/− background. The caspase-1−/− 
genotype of the resulting mice was confi   rmed by PCR 
  genotyping (not depicted) and by the inability of wild-type 
S. typhimurium to kill caspase-1−/− BMDMs (Fig. 2 A). The 
nramp1+/+ status of the mice was confi  rmed by sequencing 
(Fig. 2 B). Caspase-1−/−nramp1+/+ mice were then infected 
orally with 106 wild-type S. typhimurium ( 10 LD50 for an 
nramp1+/+ mouse). As in the case of the nramp1−/− back-
ground, the absence of caspase-1 in the context of a wild-
type allele of nramp1 also resulted in increased susceptibility 
to S. typhimurium infection as shown by the shorter time to 
death (Fig. 2 C). Consistent with these results, bacterial loads 
recovered from the spleens and MLNs 5 d after infection 
were signifi   cantly higher in caspase-1−/−nramp1+/+ when 
compared with the controls (P = 0.0016 and P < 0.0001 for 
spleens and MLNs, respectively; Fig. 2 D). Bacterial loads 
in mice carrying both mutations (i.e., caspase1−/−nramp1−/−) 
were much higher than in mice carrying a mutation in either 
allele (Fig. 2 D), indicating that Nramp1 and caspase-1 oper-
ate in independent defense pathways against S. typhimurium. 
These experiments demonstrate that the ability of S. ty-
phimurium to kill macrophages in a caspase-1–dependent 
manner is not required for bacteria to cross the intestinal bar-
rier and become systemic, and that caspase-1 defi  ciency leads 
to an increased susceptibility to infection.
Previous studies have shown that the SPI-1 TTSS plays 
a very important role in the colonization of PPs before its 
translocation to systemic sites (21, 22). To investigate whether 
the SPI-1 TTSS– and caspase-1–dependent macrophage 
death was important for S. typhimurium colonization of PPs, 
we compared the bacterial loads at this site after infection of 
wild-type and caspase1−/− mice. We found that absence of 
caspase-1 did not decrease but slightly increased (P = 0.114 
and P = 0.259 in nramp1−/− and nramp1+/+ backgrounds, 
respectively) the bacterial loads in PPs in both nramp1−/− and 
nramp1+/+ backgrounds (Fig. 2 E), further supporting the con-
clusion that translocation of S. typhimurium to this site does 
not require the SPI-1 TTSS–mediated caspase-1–dependent 
macrophage death.
In the mouse, S. typhimurium causes a systemic disease 
that more closely resembles typhoid fever than gastroenter-
itis, the syndrome that this bacterium most often causes in 
  humans. However, in mice pretreated with antibiotics, 
S. typhimurium causes acute colitis, which has been used as a 
model for the study of S. typhimurium–induced intestinal in-
fl  ammation (23). Previous studies have demonstrated that the 
SPI-1–encoded TTSS plays an important role in the ability of 
S. typhimurium to induce colitis in the streptomycin-treated 
mouse model (24). However, it is unknown whether the 
ability of S. typhimurium to rapidly kill macrophages through 
the activity of its SPI-1–encoded TTSS plays a role in the in-
duction of infl  ammation in this model system. We therefore 
compared the ability of S. typhimurium to induce colitis in 
wild-type and caspase-1–defi  cient mice because the SPI-1–
dependent  S. typhimurium–induced macrophage death is 
  dependent on caspase-1. Streptomycin-pretreated caspase-1−/− 
and control mice were orally infected with S. typhimurium, 
and 48 h after infection, ceca were removed for histopatho-
logical analysis. Streptomycin-treated uninfected mice exhib-
ited normal histology of the intestinal epithelium (Fig. 3 A). 
In contrast, streptomycin-treated S. typhimurium–infected cas-
pase-1+/+ mice showed marked infl  ammation of the intesti-
nal epithelium (Fig. 3 A). The cecum histopathology of the 
infected animals was characterized by profuse mucosal edema, 
marked infi  ltration of neutrophils, and substantial disruption 
of the epithelium. caspase-1−/− mice showed even more pro-
nounced infl  ammation than control mice (Fig. 3 A). The le-
sions in the caspase-1−/− mice showed more edema, more 
neutrophil infi  ltration, and epithelial disruption. The more 
pronounced histopathological changes could not be ascribed 
to higher bacterial burden because there was not a signifi  cant 
diff  erence in the bacterial loads recovered from this tissue in 
both types of animals (Fig. 3 B). Rather, the more pro-
nounced histopathology may be the result of S. typhimurium 
reaching deeper tissues in the absence of caspase-1. These re-
sults indicate that the ability of S. typhimurium to cause in-
fl  ammation in the cecum is largely independent of its ability 
to activate caspase-1. Furthermore, contrary to what has been 
reported previously (8), the ability of S. typhimurium to rap-
idly kill macrophages in a SPI-1 TTSS– and caspase-1–de-
pendent manner does not seem to contribute signifi  cantly to 
its ability to cause colitis. Because the SPI-1 TTSS has been 
shown to be essential for S. typhimurium to cause colitis (24), 
activities mediated by this TTSS other than macrophage kill-
ing must be more important for the stimulation of the in-
fl  ammatory response.
Caspase-1 is activated upon assembly of an intracellular 
complex known as the infl  ammasome. IPAF and NALP3 are 
key components of this multi-protein complex (2, 25). IPAF 
is a CARD-containing protein and has been shown to bind the 
CARD domain of caspase-1 resulting in caspase-1 activation 1410  THE INFLAMMASOME AND SALMONELLA PATHOGENESIS | Lara-Tejero et al. 
(26). NALP3 activates caspase-1 through the adaptor molecule 
ASC (apoptosis-associated speck-like protein containing a 
CARD) (27). ASC is essential for the caspase-1 activation 
  mediated by several pathogen-associated molecular patterns 
(13, 28). Recent studies have also shown that S. typhimurium 
can kill asc−/− BMDMs, although it does so with delayed 
  kinetics, indicating that ASC is not essential for S. typhimurium 
TTSS-dependent caspase-1 activation (13). In contrast, ipaf−/− 
BMDMs failed to show activation of caspase-1 upon bacterial 
infection and were as resistant to S. typhimurium–induced death 
as caspase-1−/− BMDMs (13). These results suggest that IPAF 
and caspase-1 are in the same pathway of bacterial-induced 
death. However, ipaf−/− BMDMs did not show any defect in 
caspase-1 activation when stimulated with pathogen- associated 
molecular patterns and ATP (13), indicating the existence of 
alternative pathways of caspase-1 activation. NALP3, another 
component of the infl   ammasome, has been implicated in 
the ASC-dependent activation of caspase-1 (29). However, 
nalp3−/− BMDMs were fully susceptible to the Salmonella-
  induced death (30, 31). Collectively, these results suggest the 
existence of at least two diff  erent pathways leading to caspase-1 
activation, one mediated by NALP3 and the adaptor molecule 
ASC (resulting in proinfl  ammatory cytokine production) and 
the other mediated by IPAF (resulting in cell death). Whether 
the diff  erent outputs are the result of diff  erent levels of caspase-1 
activation or the result of the recruitment of diff  erent caspase-1 
eff  ectors is unclear.
Given the observation that S. typhimurium is capable of 
activating the infl  ammasome and caspase-1 by diff  erent path-
ways, we examined the role of diff  erent components of the 
infl  ammasome in S. typhimurium pathogenesis. nalp3+/+ and 
nalp3−/− mice (carrying the nramp1 mutant allele) were in-
fected orally with 105 wild-type S. typhimurium, and survival 
was monitored daily. Both nalp3+/+ and nalp3−/− succumbed 
to bacterial infection within the same time frame (Fig. 4 A) 
and exhibited similar bacterial loads in the spleens and MLNs 
5 d after infection (Fig. 4 B). We also examined the suscepti-
bility of asc−/− mice to S. typhimurium infection. Similar to 
nalp3−/− mice, ASC defi  ciency did not change the suscepti-
bility to S. typhimurium infection as measured by time to 
death and bacterial loads in diff  erent tissues (Fig. 4, C and D). 
Because the absence of caspase-1 resulted in increased suscep-
tibility to S. typhimurium infection (Figs. 1 and 2), these re-
sults suggest that S. typhimurium must be able to activate 
caspase-1 independently of NALP3 and ASC. Previous stud-
ies have also shown that IPAF-defi   cient macrophages are 
  resistant to S. typhimurium–induced death, suggesting an 
  important role for IPAF in S. typhimurium–induced caspase-1 
activation (13). Therefore, we examined the susceptibility of 
ipaf−/− mice to oral S. typhimurium. ipaf+/+ and ipaf−/− mice 
(carrying the nramp1 mutant allele) were infected orally with 
106 S. typhimurium, and the bacterial loads in the spleens and 
MLNs 5 d after infection were determined. IPAF defi  ciency 
did not increase resistance to S. typhimurium infection (Fig. 4 E). 
In contrast, the bacterial loads were slightly higher in the 
ipaf−/− mice, although the diff  erence was not statistically sig-
nifi  cant. The observation that the bacterial loads in systemic 
tissues were not reduced in the ipaf−/− mice further supports 
the notion that the IPAF- and caspase-1–dependent Salmo-
nella-induced macrophage death is not required for these 
bacteria to cross the intestinal barrier.
Collectively, these results, combined with previously 
published reports (13, 30, 31), indicate that S. typhimurium 
Figure 3.  Histopathology of ceca from streptomycin-treated wild-
type and caspase-1−/− mice orally infected with S. typhimurium. 
(A) Wild-type and caspase-1− /− mice (nramp-1+/+ background) were treated 
with 20 mg streptomycin, and 24 h after antibiotic treatment, mice were 
either mock infected (control) or infected orally with 108 S. typhimurium. 
48 h after infection, ceca were removed, fi  xed, and embedded in paraffi  n, 
and tissue sections were stained with hematoxylin and eosin. Similar re-
sults were obtained in three independent animals for each group. (B) Mice 
were treated and infected with S. typhimurium as indicated above, and 
bacterial loads in the spleens and ceca were determined 48 h after infec-
tion (p-values for the difference between the bacterial loads in the spleens 
and ceca of caspase-1−/− vs. caspase-1+/+ mice were P = 0.138 and 
P = 0.483, respectively).JEM VOL. 203, June 12, 2006  1411
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possesses diff  erent redundant mechanisms to activate caspase-1 
through diff  erent components of the infl  ammasome.  Fur-
thermore, these results indicate that contrary to what has 
been proposed previously, the absence of caspase-1 does not 
result in resistance to S. typhimurium infection and that this 
pathogen does not require the activity of this enzyme to cross 
the intestinal barrier.
MATERIALS AND METHODS
Mouse strains. The caspase-1−/−, nalp3−/−, and asc−/− mouse lines have 
been described previously (7, 30) and were backcrossed to the C57BL/6 
background for fi  ve (caspase-1−/− and nalp3−/−) and six (asc−/−) generations. 
To generate ipaf−/− mice, an IPAF targeting vector (Fig. S1 A, available at 
http://www.jem.org/cgi/content/full/jem.20060206/DC1) was electro-
porated into 129SvEvBrd Lex-1 ES cells. Homologous recombinant ES cells 
were identifi  ed by Southern blot analysis and microinjected into C57BL/6 
blastocysts. Chimeric off  spring were backcrossed to C57BL/6 mice, and germ-
line transmission was confi  rmed by PCR of tail genomic DNA (Fig. S1 B). 
Screening of IPAF mice using the primers (no. 28) 5′-G  C  A  G  G  A  A  T  C  A  A  T-
C  C  A  G  A  G  T  C  T  G  A  G   and (no. 37) 5′-G  A  A  G  C  C  T  C  A  A  C  G  G  C  A  A  C  G  A  G  C-
A  C  T  C   amplify a 744-bp product from the wild-type allele. Primers (no. 37) 
5′-G  A  A  G  C  C  T  C  A  A  C  G  G  C  A  A  C  G  A  G  C  A  C  T  C   and (Neo3A) 5′-G  C  A  G  C-
G  C  A  T  C  G  C  C  T  T  C  T  A  T  C   amplify a 222-bp product from the targeted 
  allele. RT-PCR analysis of cDNA isolated from ipaf+/+, ipaf+/−, and ipaf−/− 
splenocytes (Fig. S1 C) confi  rmed the absence of IPAF mRNA in ipaf−/− 
mice. Primers used for RT-PCR analysis were as follows: GAPDH, T  C  A  C-
C  A  C  C  A  T  G  G  A  G  A  A  G  G  C   and G  C  T  A  A  G  C  A  G  T  T  G  G  T  G  G  T  G  C  A  ; IPAF, 
A  T  G  T  C  A  T  T  T  A  C  T  G  T  G  A  G  C  C  C  T  T  G  G   and T  T  G  C  C  A  G  A  C  T  C  G  C  C  T-
T  C  A  A  T  C  . IPAF-defi  cient mice were backcrossed onto a C57BL/6 back-
ground for two generations. All mice were used at 8–12 wk of age. Wild-type 
littermates were used as controls.
Nramp1 genotyping. A 514-bp fragment of the nramp1 gene was ampli-
fi  ed by PCR using primers 5′-A  A  G  T  G  A  C  A  T  C  T  C  G  C  C  A  T  A  G  G  T  G  C  C  -3′ 
and 5′-T  T  C  T  C  T  C  A  C  C  A  T  A  G  T  T  A  T  C  C  A  A  G   AAG-3′ (forward and 
  reverse, respectively). The purifi  ed PCR product was then sequenced using 
the primer 5′-C  C  C  C  C  A  T  C  T  A  T  G  T  T  A  T  C  A  C  C  C  -3′.
S. typhimurium strains. S. typhimurium SL1344 was the wild-type strain 
used in all the experiments. SB161 and SL1344 derivative carrying a nonpo-
lar mutation in the invG gene, which encodes an essential component of the 
SPI-1 TTSS, has been described previously (9). To prepare cultures for cy-
totoxicity assays or infection of mice, overnight cultures were subcultured 
for 4 h in LB medium containing 0.3 M NaCl to an OD600 of 0.9 to induce 
expression of the SPI-1–encoded TTSS.
Cytotoxicity assays. BMDMs were seeded on 24-well tissue culture dishes 
at 2 × 105 cells/well density. Before infection, the complete medium was 
replaced by serum-free HBSS. Bacteria grown as described above were added 
to wells at a multiplicity of infection of 20 bacteria/cell, and supernatant samples 
were collected at the indicated time points to be assayed for lactate dehydro-
genase (LDH) activity as a marker for cell death. LDH assays were performed 
using the CytoTox 96 nonradioactive cytotoxicity assay (Promega).
Animal infection experiments. All animal experiments were conducted 
according to protocols approved by Yale University’s Institutional Animal 
Care and Use Committee. Groups of age- and sex-matched mice were 
  infected at 8–12 wk of age. After 8 h of fasting, mice were administered by 
intragastric gavage 100 μl of 10% bicarbonate solution followed by the indi-
cated bacterial dose in 100 μl PBS. To determine bacterial loads in the spleens 
and MLNs, mice were killed 5 d after infection, organs were homogenized in 
3 ml PBS containing 0.05% sodium deoxycholate, and dilutions were plated 
on LB plates containing streptomycin to determine colony-forming units.
S. typhimurium–induced colitis model in streptomycin-treated mice. 
Bacterial infections in streptomycin-treated animals were performed 
  essentially as described previously (23). In brief, mice (three per group) were 
treated orally with 20 mg streptomycin, and 24 h after antibiotic treatment, 
mice were infected orally with wild-type S. typhimurium as described above. 
Mice were killed 48 h after infection, and ceca were fi  xed in formalin for 
histopathology processing. Fixed tissues were embedded in paraffi   n,  and 
  tissue sections were stained with hematoxylin and eosin. In a parallel identical 
experiment, ceca were homogenized in 3 ml PBS containing 0.05% sodium 
deoxycholate and dilutions were plated on LB plates containing streptomycin 
to determine colony-forming units.
Online supplemental material. Fig. S1 shows the targeted   disruption 
of the murine IPAF gene and is available at http://www.jem.org/cgi/
content/full/jem.20060206/DC1.
Figure 4.  Susceptibility to S. typhimurium infection of mice defi  -
cient in essential components of the infl  ammasome. (A) nalp3+/+ and 
nalp3−/− mice were infected orally with 105 wild-type S. typhimurium, 
and survival was monitored over time. (B) nalp3+/+ and nalp3−/− mice 
were infected orally with 106 S. typhimurium, and the bacterial loads in 
the spleens and MLNs were determined 5 d after infection. (C) asc+/+ and 
asc−/− mice were infected orally with 105 wild-type S. typhimurium, and 
survival was monitored over time. (D) asc+/+ and asc−/− mice were in-
fected orally with 106 S. typhimurium, and the bacterial loads in the 
spleens and MLNs were determined 5 d after infection. (E) ipaf+/+ and 
ipaf−/− mice were infected orally with 106 S. typhimurium, and the bacte-
rial loads in the spleens and MLNs were determined 5 d after infection.1412  THE INFLAMMASOME AND SALMONELLA PATHOGENESIS | Lara-Tejero et al. 
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